(Q34284970)

1 August 2017

Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumours with long acting somatostatin analogue (English)

1 reference

1 August 2017

Ch'ng JL

1

1 reference

1 August 2017

Anderson JV

2

1 reference

1 August 2017

Williams SJ

3

1 reference

1 August 2017

Carr DH

4

1 reference

1 August 2017

Bloom SR

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

1 August 2017

1 reference

1 August 2017

292

1 reference

1 August 2017

6526

1 reference

1 August 2017

981-982

1 reference

Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea

1 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339916

Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339916

Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339916

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

6 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2870758

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.292.6526.981

0 references

PMCID

1339916

1 reference

1 August 2017

1 reference